Caffeine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
2D structure of caffeine
3D structure of caffeine
Systematic (IUPAC) name
1,3,7-Trimethylpurine-2,6-dione
Clinical data
Pronunciation /kæˈfn, ˈkæfn/
AHFS/Drugs.com monograph
Pregnancy
category
  • AU: A
  • US: C (Risk not ruled out)
Legal status
  • Unscheduled
Dependence
liability
Physical: low–moderate[1][2][3][4]
Psychological: low[5]
Addiction
liability
Low[4] / None[1][2][3]
Routes of
administration
By mouth, insufflation, enema, rectal, intravenous
Pharmacokinetic data
Bioavailability 99%[6]
Protein binding 25–36%[7]
Metabolism Primary: CYP1A2[7]
Minor: CYP2E1,[7] CYP3A4,[7] CYP2C8,[7] CYP2C9[7]
Metabolites Paraxanthine (84%)
Theobromine (12%)
Theophylline (4%)
Onset of action ~1 hour[6]
Biological half-life Adults: 3–7 hours[7]
Neonates: 65–130 hours[7]
Duration of action 3–4 hours[6]
Excretion Urine (100%)
Identifiers
CAS Number 58-08-2 YesY
ATC code N06BC01 (WHO)
PubChem CID: 2519
IUPHAR/BPS 407
DrugBank DB00201 YesY
ChemSpider 2424 YesY
UNII 3G6A5W338E YesY
KEGG D00528 YesY
ChEBI CHEBI:27732 YesY
ChEMBL CHEMBL113 YesY
Synonyms Guaranine
Methyltheobromine
1,3,7-Trimethylxanthine
Theine
PDB ligand ID CFF (PDBe, RCSB PDB)
Chemical data
Formula C8H10N4O2
Molecular mass 194.19 g/mol
Physical data
Density 1.23 g/cm3
Melting point 235 to 238 °C (455 to 460 °F) (anhydrous)[8][9]
See also: data page

Caffeine is a central nervous system (CNS) stimulant of the methylxanthine class.[10] It is the world's most widely consumed psychoactive drug. Unlike many other psychoactive substances, it is legal and unregulated in nearly all parts of the world. There are several known mechanisms of action to explain the effects of caffeine. The most prominent is that it reversibly blocks the action of adenosine on its receptor and consequently prevents the onset of drowsiness induced by adenosine. Caffeine also stimulates certain portions of the autonomic nervous system.

Caffeine is a bitter, white crystalline purine, a methylxanthine alkaloid, and is chemically related to the adenine and guanine bases of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). It is found in the seeds, nuts, or leaves of a number of plants native to South America and East Asia and helps to protect them against predator insects and to prevent germination of nearby seeds. The most well known source of caffeine is the coffee bean, a misnomer for the seed of Coffea plants. Beverages containing caffeine are ingested to relieve or prevent drowsiness and to improve performance. To make these drinks, caffeine is extracted by steeping the plant product in water, a process called infusion. Caffeine-containing drinks, such as coffee, tea, and cola, are very popular; in 2005, 90% of North American adults consumed caffeine daily.[11]

Caffeine can have both positive and negative health effects. It can treat and prevent the premature infant breathing disorders bronchopulmonary dysplasia of prematurity and apnea of prematurity. Caffeine citrate is on the WHO Model List of Essential Medicines.[12] It may confer a modest protective effect against some diseases,[13] including Parkinson's disease[14] and certain types of cancer. One meta-analysis concluded that cardiovascular disease such as coronary artery disease and stroke is less likely with 3–5 cups of non-decaffeinated coffee per day but more likely with over 5 cups per day.[15] Some people experience insomnia or sleep disruption if they consume caffeine, especially during the evening hours, but others show little disturbance. Evidence of a risk during pregnancy is equivocal; some authorities recommend that pregnant women limit consumption to the equivalent of two cups of coffee per day or less.[16][17] Caffeine can produce a mild form of drug dependence – associated with withdrawal symptoms such as sleepiness, headache, and irritability – when an individual stops using caffeine after repeated daily intake.[1][3][5] Tolerance to the autonomic effects of increased blood pressure and heart rate, and increased urine output, develops with chronic use (i.e., these symptoms become less pronounced or do not occur following consistent use).[18]

Caffeine is classified by the Food and Drug Administration as "generally recognized as safe" (GRAS). Toxic doses, over 10 grams per day for an adult, are much higher than typical doses of under 500 milligrams per day. A cup of coffee contains 80–175 mg of caffeine, depending on what "bean" (seed) is used and how it is prepared (e.g. drip, percolation, or espresso). Thus it requires roughly 50–100 ordinary cups of coffee to reach a lethal dose. However pure powdered caffeine, which is available as a dietary supplement, can be lethal in tablespoon-sized amounts.

Use

Medical

Caffeine is used in:

Enhancing performance

Cognitive

Caffeine is a central nervous system stimulant that reduces fatigue and drowsiness.[10] At normal doses, caffeine has variable effects on learning and memory, but it generally improves reaction time, wakefulness, concentration, and motor coordination.[29][30] The amount of caffeine needed to produce these effects varies from person to person, depending on body size and degree of tolerance.[29] The desired effects arise approximately one hour after consumption, and the desired effects of a moderate dose usually subside after about three or four hours.[6]

Caffeine can delay or prevent sleep, and improves task performance during sleep deprivation.[31] Shift workers who use caffeine make fewer mistakes due to drowsiness.[32]

A systematic review and meta-analysis from 2014 found that concurrent caffeine and L-theanine use has synergistic psychoactive effects that promote alertness, attention, and task switching;[33] these effects are most pronounced during the first hour post-dose.[33]

Physical

Caffeine is a proven ergogenic aid in humans.[34] Caffeine improves athletic performance in aerobic (especially endurance sports) and anaerobic conditions.[34] Moderate doses of caffeine (around 5 mg/kg[34]) can improve sprint performance,[35] cycling and running time trial performance,[34] endurance (i.e., it delays the onset of muscle fatigue and central fatigue),[34][36][37] and cycling power output.[34]

Specific populations

Adults

For the general population of healthy adults, Health Canada advises a daily intake of no more than 400 mg.[38]

Children

In healthy children, caffeine intake produces effects that are "modest and typically innocuous".[39] There is no evidence that coffee stunts a child's growth.[40] For children age 12 and under, Health Canada recommends a maximum daily caffeine intake of no more than 2.5 milligrams per kilogram of body weight. Based on average body weights of children, this translates to the following age-based intake limits:[38]

Age range Maximum recommended daily caffeine intake
4–6 45 mg (slightly more than in 12 oz of a typical soft drink)
7–9 62.5 mg
10–12 85 mg (about ½ cup of coffee)

Adolescents

Health Canada has not developed advice for adolescents because of insufficient data. However, they suggest that daily caffeine intake for this age group be no more than 2.5 mg/kg body weight. This is because the maximum adult caffeine dose may not be appropriate for light weight adolescents or for younger adolescents who are still growing. The daily dose of 2.5 mg/kg body weight would not cause adverse health effects in the majority of adolescent caffeine consumers. This is a conservative suggestion since older and heavier weight adolescents may be able to consume adult doses of caffeine without suffering adverse effects.[38]

Pregnancy and breastfeeding

The UK Food Standards Agency has recommended that pregnant women should limit their caffeine intake, out of prudence, to less than 200 mg of caffeine a day – the equivalent of two cups of instant coffee, or one and a half to two cups of fresh coffee.[41] The American Congress of Obstetricians and Gynecologists (ACOG) concluded in 2010 that caffeine consumption is safe up to 200 mg per day in pregnant women.[17] For women who breastfeed, are pregnant, or may become pregnant, Health Canada recommends a maximum daily caffeine intake of no more than 300 mg, or a little over two 8 oz (237 mL) cups of coffee.[38]

The evidence for or against the importance of limiting caffeine intake during pregnancy is insufficient and of weak quality.[42] There are conflicting reports in the scientific literature about caffeine consumption during pregnancy.[43] A 2011 risk analysis review found that caffeine consumption during pregnancy does not appear to increase the risk of congenital malformations, miscarriage or growth retardation even when consumed in moderate to high amounts.[44] There is some evidence that the hormonal changes during pregnancy slow the metabolic clearance of caffeine from the system, causing a given dose to have longer-lasting effects (as long as 15 hours in the third trimester).[45] There is some evidence that higher caffeine intake by pregnant women may be associated with a higher risk of giving birth to a low birth weight baby,[46] and may be associated with a higher risk of pregnancy loss.[47] A systematic review, analyzing the results of observational studies, suggests that women who consume large amounts of caffeine (greater than 300 mg/day) prior to becoming pregnant may have a higher risk of experiencing pregnancy loss.[48]

Side effects

Side effects of caffeine

Physical

Caffeine can increase blood pressure and cause vasoconstriction.[49][50][51] Long-term consumption at sufficiently high doses has been associated with chronic arterial stiffness.[51] Coffee and caffeine can affect gastrointestinal motility and gastric acid secretion.[52][53][54]

Caffeine increases basal metabolic rate in adults.[55][56][57] In postmenopausal women, high caffeine consumption can accelerate bone loss.[58][59]

Doses of caffeine equivalent to the amount normally found in standard servings of tea, coffee and carbonated soft drinks appear to have no diuretic action.[60] However, acute ingestion of caffeine in large doses (at least 250–300 mg, equivalent to the amount found in 2–3 cups of coffee or 5–8 cups of tea) results in a short-term stimulation of urine output in individuals who have been deprived of caffeine for a period of days or weeks.[60] This increase is due to both a diuresis (increase in water excretion) and a natriuresis (increase in saline excretion); it is mediated via proximal tubular adenosine receptor blockade.[61] The acute increase in urinary output may increase the risk of dehydration. However, chronic users of caffeine develop a tolerance to this effect, and experience no increase in urinary output.[62][63]

Caffeine in low doses may cause weak bronchodilation for up to four hours in asthmatics.[64]

Psychological

Minor undesired symptoms from caffeine ingestion not sufficiently severe to warrant a psychiatric diagnosis are common, and include mild anxiety, jitteriness, insomnia, increased sleep latency, and reduced coordination.[29][65] Caffeine can have negative effects on anxiety disorders.[66] According to a 2011 literature review, caffeine use is positively associated with anxiety and panic disorders.[67] At high doses, typically greater than 300 mg, caffeine can both cause and worsen anxiety.[68] For some people, discontinuing caffeine use can significantly reduce anxiety.[69]

In moderate doses, caffeine may reduce symptoms of depression and lower suicide risk.[70]

Some textbooks state that caffeine is a mild euphoriant,[71][72][73] others state that it is not a euphoriant,[74][75] and one states that it is and is not a euphoriant.[76]

Reinforcement disorders

Addiction

Whether or not caffeine can result in an addictive disorder depends on how addiction is defined. Some diagnostic models, such as the ICDM-9 and ICD-10, include a classification of caffeine addiction under a broader diagnostic model.[77] Some state that certain users can become addicted and therefore unable to decrease use even though they know there are negative health effects.[78][79]

Caffeine does not appear to be a reinforcing stimulus, and some degree of aversion may actually occur, with people preferring placebo over caffeine in a study on drug abuse liability published in an NIDA research monograph.[80] Some state that research does not provide support for an underlying biochemical mechanism for caffeine addiction.[1][81][82][83] Other research states it can affect the reward system.[84]

"Caffeine addiction" was added to the ICDM-9 and ICD-10. However, its addition was contested with claims that this diagnostic model of caffeine addiction is not supported by evidence.[1][2][85] The American Psychiatric Association's DSM-5 does not include the diagnosis of a caffeine addiction but proposes criteria for the disorder for more study.[86][87]

Dependence and withdrawal

Withdrawal can cause mild to clinically significant distress or impairment in daily functioning. The frequency at which this occurs is self reported at 11%, but in lab tests only half of the people who report withdrawal actually experience it, casting doubt on many claims of dependence.[88][89] Mild[1] to increasingly severe physical dependence and withdrawal symptoms may occur upon abstinence, with greater than 100 mg caffeine per day;[89] some symptoms associated with psychological dependence may also occur during withdrawal.[5] Caffeine dependence can involve withdrawal symptoms such as fatigue, headache, irritability, depressed mood, reduced contentedness, inability to concentrate, sleepiness or drowsiness, stomach pain, and joint pain.[1][5] Withdrawal headaches are experienced by roughly half of those who stop consuming caffeine for two days following an average daily intake of 235 mg.[90]

The ICD-10 includes a diagnostic model for caffeine dependence, but the DSM-5 does not.[3][85] The APA, which published the DSM-5, acknowledged that there was sufficient evidence in order to create a diagnostic model of caffeine dependence for the DSM-5, but they noted that the clinical significance of this disorder is unclear.[3] The DSM-5 instead lists "caffeine use disorder" in the emerging models section of the manual.[3]

Tolerance varies for daily, regular caffeine users and high caffeine users. High doses of caffeine (750 to 1200 mg/day spread throughout the day) have been shown to produce complete tolerance to some, but not all of the effects of caffeine. Doses as low as 100 mg/day, such as a 6 oz cup of coffee or two to three 12 oz servings of caffeinated soft-drink, may continue to cause sleep disruption, among other intolerances. Non-regular caffeine users have the least caffeine tolerance for sleep disruption.[89] Some coffee drinkers develop tolerance to its undesired sleep-disrupting effects, but others apparently do not.[45]

Effect of genetics on withdrawal symptoms

Gene polymorphism could be associated with caffeine withdrawal symptoms and beta-1 and beta-2 play roles in caffeine withdrawal.[91] For example, compared to people with homozygous Gly16 allele, people with the heterozygote ADR beta-2 Gly16 Arg gene polymorphism have a higher chance of feeling fatigue after 48 hours of caffeine withdrawal.[91] It has been suspected that beta2- adrenoceptors are the main cause for this increase in mental fatigue symptoms.[91] Beta 2- adrenoceptors are receptors that regulate glycogenolysis, secret insulin and intramuscularly transport glucose that is used for cerebral and muscle activity.[91] Another example is given by the genes ADRbeta1 Gly16 Arg and CYP1A2-163A>C polymorphisms.[91] They are associated with peoples' mood swings and increased depression level.[91] Among subjects homozygous for the CYP1A2 allele, ADRbeta1 Gly389 allele carriers are reported to have a higher percentage of depression level increase when compared to Arg389 homozygotes subjects.[91] Adrenergic receptors, again, play a key role in this symptom, as altered norepinephrine (an adrenoceptor agonist) neurotransmission contribute to the etiology of depression.[91] This symptom is often seen in faster caffeine metabolizers, because caffeine effects diminish quicker in these people and provide them less opportunity to adapt to caffeine loss.[91]

Risk of other diseases

Coffee consumption is associated with a lower overall risk of cancer.[92] This is primarily due to a decrease in the risks of hepatocellular and endometrial cancer, but it may also have a modest effect on colorectal cancer.[93] There does not appear to be a significant protective effect against other types of cancers, and heavy coffee consumption may increase the risk of bladder cancer.[93]

A protective effect of caffeine against Alzheimer's disease is possible, but the evidence is inconclusive.[94][95][96] Moderate coffee consumption may decrease the risk of cardiovascular disease,[15] and it may somewhat reduce the risk of type 2 diabetes.[97] Drinking four or more cups of coffee per day does not affect the risk of hypertension compared to drinking little or no coffee; however, drinking 1–3 cups per day may be at a slightly increased risk.[98] Caffeine increases intraocular pressure in those with glaucoma but does not appear to affect normal individuals.[99] It may protect people from liver cirrhosis.[100] Caffeine may increase the effectiveness of some medications including ones used to treat headaches.[101] Caffeine may lessen the severity of acute mountain sickness if taken a few hours prior to attaining a high altitude.[102]

Overdose

Torso of a young man with overlaid text of main side-effects of caffeine overdose.
Primary symptoms of caffeine intoxication[103]

Consumption of 1–1.5 grams per day is associated with a condition known as caffeinism.[104] Caffeinism usually combines caffeine dependency with a wide range of unpleasant symptoms including nervousness, irritability, restlessness, insomnia, headaches, and palpitations after caffeine use.[105]

Caffeine overdose can result in a state of central nervous system over-stimulation called caffeine intoxication (DSM-IV 305.90).[106] This syndrome typically occurs only after ingestion of large amounts of caffeine, well over the amounts found in typical caffeinated beverages and caffeine tablets (e.g., more than 400–500 mg at a time). The symptoms of caffeine intoxication are comparable to the symptoms of overdoses of other stimulants: they may include restlessness, fidgeting, anxiety, excitement, insomnia, flushing of the face, increased urination, gastrointestinal disturbance, muscle twitching, a rambling flow of thought and speech, irritability, irregular or rapid heart beat, and psychomotor agitation.[103] In cases of much larger overdoses, mania, depression, lapses in judgment, disorientation, disinhibition, delusions, hallucinations, or psychosis may occur, and rhabdomyolysis (breakdown of skeletal muscle tissue) can be provoked.[107][108]

Massive overdose can result in death.[109][110] The LD50 of caffeine in humans is dependent on individual sensitivity, but is estimated to be 150 to 200 milligrams per kilogram of body mass (75–100 cups of coffee for a 70 kilogram adult).[111] A number of fatalities have been caused by overdoses of readily available powdered caffeine supplements, for which the estimated lethal amount is less than a tablespoon.[112] The lethal dose is lower in individuals whose ability to metabolize caffeine is impaired due to genetics or chronic liver disease[113] A death was reported in a man with liver cirrhosis who overdosed on caffeinated mints.[114][115][116]

Treatment of mild caffeine intoxication is directed toward symptom relief; severe intoxication may require peritoneal dialysis, hemodialysis, or hemofiltration.[103]

Interactions

Alcohol

According to DSST, alcohol provides a reduction in performance and caffeine has a significant improvement in performance.[117] When alcohol and caffeine are consumed jointly, the effects produced by caffeine are affected, but the alcohol effects remain the same.[118] For example, when additional caffeine is added, the drug effect produced by alcohol is not reduced.[118] However, the jitteriness and alertness given by caffeine is decreased when additional alcohol is consumed.[118] Alcohol consumption alone reduces both inhibitory and activational aspects of behavioral control. Caffeine antagonizes the activational aspect of behavioral control, but has no effect on the inhibitory behavioral control.[119]

Tobacco

Smoking tobacco increases caffeine clearance by 56%.[120]

Oral birth control

Consumption of caffeine while orally administering birth control can extend the half-life of caffeine; therefore, greater attention should be taken during caffeine consumption.[121]

Pharmacology

Pharmacodynamics

Structure of a typical chemical synapse
Two skeletal formulas: left – caffeine, right – adenosine.
Caffeine's primary mechanism of action is as an antagonist of adenosine receptors in the brain

In the absence of caffeine and when a person is awake and alert, little adenosine is present in (CNS) neurons. With a continued wakeful state, over time it accumulates in the neuronal synapse, in turn binding to and activating adenosine receptors found on certain CNS neurons; when activated, these receptors produce a cellular response that ultimately increases drowsiness. When caffeine is consumed, it antagonizes adenosine receptors; in other words, caffeine prevents adenosine from activating the receptor by blocking the location on the receptor where adenosine binds to it. As a result, caffeine temporarily prevents or relieves drowsiness, and thus maintains or restores alertness.[7]

Receptor and ion channel targets

Caffeine is a receptor antagonist at all adenosine receptor subtypes (A1, A2A, A2B, and A3 receptors).[7] Antagonism at these receptors stimulates the medullary vagal, vasomotor, and respiratory centers, which increases respiratory rate, reduces heartrate, and constricts blood vessels.[7] Adenosine receptor antagonism also promotes neurotransmitter release (e.g., monoamines and acetylcholine), which endows caffeine with its stimulant effects;[7][122] adenosine acts as an inhibitory neurotransmitter that suppresses activity in the central nervous system. Heart palpitations are caused by blockade of the adenosine A1 receptor.[7]

Because caffeine is both water- and lipid-soluble, it readily crosses the blood–brain barrier that separates the bloodstream from the interior of the brain. Once in the brain, the principal mode of action is as a nonselective antagonist of adenosine receptors (in other words, an agent that reduces the effects of adenosine). The caffeine molecule is structurally similar to adenosine, and is capable of binding to adenosine receptors on the surface of cells without activating them, thereby acting as a competitive antagonist.[123]

In addition to its activity at adenosine receptors, caffeine is an inositol trisphosphate receptor 1 antagonist and a voltage-independent activator of the ryanodine receptors (RYR1, RYR2, and RYR3).[124] It is also a competitive antagonist of the ionotropic glycine receptor.[125]

Effects on striatal dopamine

While caffeine does not directly bind to any dopamine receptors, it influences the binding activity of dopamine at its receptors in the striatum by binding to adenosine receptors that have formed GPCR heteromers with dopamine receptors, specifically the A1D1 receptor heterodimer (this is a receptor complex with 1 adenosine A1 receptor and 1 dopamine D1 receptor) and the A2AD2 receptor heterotetramer (this is a receptor complex with 2 adenosine A2A receptors and 2 dopamine D2 receptors).[126][127][128][129] The A2A–D2 receptor heterotetramer has been identified as a primary pharmacological target of caffeine, primarily because it mediates some of its psychostimulant effects and its pharmacodynamic interactions with dopaminergic psychostimulants.[127][128][129]

Caffeine also causes the release of dopamine in the dorsal striatum and nucleus accumbens core (a substructure within the ventral striatum), but not the nucleus accumbens shell, by antagonizing A1 receptors in the axon terminal of dopamine neurons and A1A2A heterodimers (a receptor complex composed of 1 adenosine A1 receptor and 1 adenosine A2A receptor) in the axon terminal of glutamate neurons.[126][130] During chronic caffeine use, caffeine-induced dopamine release within the nucleus accumbens core is markedly reduced due to drug tolerance.[126][130]

Enzyme targets

Caffeine, like other xanthines, also acts as a phosphodiesterase inhibitor.[131] As a competitive nonselective phosphodiesterase inhibitor,[132] caffeine raises intracellular cAMP, activates protein kinase A, inhibits TNF-alpha[133][134] and leukotriene[135] synthesis, and reduces inflammation and innate immunity.[135] Caffeine also affects the cholinergic system where it inhibits the enzyme acetylcholinesterase.

Off-target effects

Caffeine antagonizes adenosine A2A receptors in the ventrolateral preoptic area (VLPO), thereby reducing inhibitory GABA neurotransmission to the tuberomammillary nucleus, a histaminergic projection nucleus that activation-dependently promotes arousal.[130] Disinhibition of the tuberomammillary nucleus is the chief mechanism by which caffeine produces wakefulness-promoting effects.[130]

Pharmacokinetics

A diagram featuring 4 skeletal chemical formulas. Top (caffeine) relates to similar compounds paraxanthine, theobromine and theophylline.
Caffeine is metabolized in the liver into three primary metabolites: paraxanthine (84%), theobromine (12%), and theophylline (4%)

Caffeine from coffee or other beverages is absorbed by the small intestine within 45 minutes of ingestion and distributed throughout all bodily tissues.[136] Peak blood concentration is reached within 1–2 hours.[citation needed] It is eliminated by first-order kinetics.[137] Caffeine can also be absorbed rectally, evidenced by suppositories of ergotamine tartrate and caffeine (for the relief of migraine)[138] and chlorobutanol and caffeine (for the treatment of hyperemesis).[139] However, rectal absorption is less efficient than oral: the maximum concentration (Cmax) and total amount absorbed (AUC) are both about 30% (i.e. 1/3.5) of the oral amounts.[140]

Caffeine's biological half-life – the time required for the body to eliminate one-half of a dose – varies widely among individuals according to factors such as pregnancy, other drugs, liver enzyme function level (needed for caffeine metabolism) and age. In healthy adults, caffeine's half-life is between 3–7 hours.[7] Nicotine decreases the half-life by 30–50%,[45] while oral contraceptives can double it[45] and pregnancy can raise it to as much as 15 hours during the last trimester.[45] In newborns the half-life can be 80 hours or more, dropping very rapidly with age, possibly to less than the adult value by age 6 months.[45] The antidepressant fluvoxamine (Luvox) reduces the clearance of caffeine by more than 90%, and increases its elimination half-life more than tenfold; from 4.9 hours to 56 hours.[141]

Caffeine is metabolized in the liver by the cytochrome P450 oxidase enzyme system, in particular, by the CYP1A2 isozyme, into three dimethylxanthines,[142] each of which has its own effects on the body:

1,3,7-Trimethyluric acid is a minor caffeine metabolite.[7] Each of these metabolites is further metabolized and then excreted in the urine. Caffeine can accumulate in individuals with severe liver disease, increasing its half-life.[143]

A 2011 review found that increased caffeine intake was associated with a variation in two genes that increase the rate of caffeine catabolism. Subjects who had this mutation on both chromosomes consumed 40 mg more caffeine per day than others.[144] This is presumably due to the need for a higher intake to achieve a comparable desired effect, not that the gene led to a disposition for greater incentive of habituation.

Chemistry

Pure anhydrous caffeine is a bitter-tasting white odorless powder with a melting point of 235–238 °C.[8][9] Caffeine is moderately soluble in water at room temperature (2 g/100 mL), but very soluble in boiling water (66 g/100 mL).[145] It is also moderately soluble in ethanol (1.5 g/100 mL).[145] It is weakly basic (pKa = ~0.6) requiring strong acid to protonate it.[146] Caffeine does not contain any stereogenic centers[147] and hence is classified as an achiral molecule.[148]

The xanthine core of caffeine contains two fused rings, a pyrimidinedione and imidazole. The pyrimidinedione in turn contains two amide functional groups that exist predominately in a zwitterionic resonance the location from which the nitrogen atoms are double bonded to their adjacent amide carbons atoms. Hence all six of the atoms within the pyrimidinedione ring system are sp2 hybridized and planar. Therefore, the fused 5,6 ring core of caffeine contains a total of ten pi electrons and hence according to Hückel's rule is aromatic.[149]

Biosynthesis

The biosynthesis of caffeine is an example of convergent evolution among different species.[150][151][152]

Caffeine may be synthesized in the lab starting with dimethylurea and malonic acid.[clarification needed][154][155][156]

Commercial supplies of caffeine are not usually manufactured synthetically because the chemical it is readily available as a byproduct of decaffeination.[157]

Decaffeination

Fibrous crystals of purified caffeine. Dark field light microscope image, the image covers an area of approx. 7 x 11mm.

Extraction of caffeine from coffee, to produce caffeine and decaffeinated coffee, can be performed using a number of solvents. Benzene, chloroform, trichloroethylene, and dichloromethane have all been used over the years but for reasons of safety, environmental impact, cost, and flavor, they have been superseded by the following main methods:

  • Water extraction: Coffee beans are soaked in water. The water, which contains many other compounds in addition to caffeine and contributes to the flavor of coffee, is then passed through activated charcoal, which removes the caffeine. The water can then be put back with the beans and evaporated dry, leaving decaffeinated coffee with its original flavor. Coffee manufacturers recover the caffeine and resell it for use in soft drinks and over-the-counter caffeine tablets.[158]
  • Supercritical carbon dioxide extraction: Supercritical carbon dioxide is an excellent nonpolar solvent for caffeine, and is safer than the organic solvents that are otherwise used. The extraction process is simple: CO2 is forced through the green coffee beans at temperatures above 31.1 °C and pressures above 73 atm. Under these conditions, CO2 is in a "supercritical" state: It has gaslike properties that allow it to penetrate deep into the beans but also liquid-like properties that dissolve 97–99% of the caffeine. The caffeine-laden CO2 is then sprayed with high pressure water to remove the caffeine. The caffeine can then be isolated by charcoal adsorption (as above) or by distillation, recrystallization, or reverse osmosis.[158]
  • Extraction by organic solvents: Certain organic solvents such as ethyl acetate present much less health and environmental hazard than chlorinated and aromatic organic solvents used formerly. Another method is to use triglyceride oils obtained from spent coffee grounds.[158]

"Decaffeinated" coffees do in fact contain caffeine in many cases – some commercially available decaffeinated coffee products contain considerable levels. One study found that decaffeinated coffee contained 10 mg of caffeine per cup, compared to approximately 85 mg of caffeine per cup for regular coffee.[159]

Detection in body fluids

Caffeine can be quantified in blood, plasma, or serum to monitor therapy in neonates, confirm a diagnosis of poisoning, or facilitate a medicolegal death investigation. Plasma caffeine levels are usually in the range of 2–10 mg/L in coffee drinkers, 12–36 mg/L in neonates receiving treatment for apnea, and 40–400 mg/L in victims of acute overdosage. Urinary caffeine concentration is frequently measured in competitive sports programs, for which a level in excess of 15 mg/L is usually considered to represent abuse.[160]

Analogs

Some analog substances have been created which mimic caffeine's properties with either function or structure or both. Of the latter group are the xanthines DMPX[161] and 8-chlorotheophylline, which is an ingredient in dramamine. Members of a class of nitrogen substituted xanthines are often proposed as potential alternatives to caffeine.[162][unreliable source?] Many other xanthine analogues constituting the adenosine receptor antagonist class have also been elucidated.[163]

Some other caffeine analogs:

Natural occurrence

Around sixty plant species are known to contain caffeine.[164] Common sources are the "beans" (seeds) of the two cultivated coffee plants, Coffea arabica and C. canephora (the quantity varies, but 1.3% is a typical value[165]); in the leaves of the tea bush; and in kola nuts. Other sources include yaupon holly leaves, South American holly yerba mate leaves, seeds from Amazonian maple guarana berries, and Amazonian holly guayusa leaves. Temperate climates around the world have produced unrelated caffeine containing plants.

Caffeine in plants acts as a natural pesticide: it can paralyze and kill predator insects feeding on the plant.[166] High caffeine levels are found in coffee seedlings when they are developing foliage and lack mechanical protection.[167] In addition, high caffeine levels are found in the surrounding soil of coffee seedlings, which inhibits seed germination of nearby coffee seedlings, thus giving seedlings with the highest caffeine levels fewer competitors for existing resources for survival.[168]

The differing perceptions in the effects of ingesting beverages made from various plants containing caffeine could be explained by the fact that these beverages also contain varying mixtures of other methylxanthine alkaloids, including the cardiac stimulants theophylline and theobromine, and polyphenols that can form insoluble complexes with caffeine.[169][clarification needed]

Products

Caffeine content in select food and drugs[170][171][172][173][174]
Product Serving size Caffeine per serving (mg) Caffeine (mg/L)
Caffeine tablet (regular-strength) 1 tablet 100
Caffeine tablet (extra-strength) 1 tablet 200
Excedrin tablet 1 tablet 65
Hershey's Special Dark (45% cacao content) 1 bar (43 g or 1.5 oz) 31
Hershey's Milk Chocolate (11% cacao content) 1 bar (43 g or 1.5 oz) 10
Percolated coffee 207 mL (7.0 US fl oz) 80–135 386–652
Drip coffee 207 mL (7.0 US fl oz) 115–175 555–845
Coffee, decaffeinated 207 mL (7.0 US fl oz) 5–15 24–72
Coffee, espresso 44–60 mL (1.5–2.0 US fl oz) 100 1,691–2,254
Tea – black, green, and other types, – steeped for 3 min. 177 millilitres (6.0 US fl oz) 22–74[173][174] 124–418
Guayakí yerba mate (loose leaf) 6 g (0.21 oz) 85[175] approx. 358
Coca-Cola Classic 355 mL (12.0 US fl oz) 34 96
Mountain Dew 355 mL (12.0 US fl oz) 54 154
Pepsi Max 355 mL (12.0 US fl oz) 69 194
Guaraná Antarctica 350 mL (12 US fl oz) 30 100
Jolt Cola 695 mL (23.5 US fl oz) 280 403
Red Bull 250 mL (8.5 US fl oz) 80 320

Products containing caffeine are coffee, tea, soft drinks ("colas"), energy drinks, other beverages, chocolate,[176] caffeine tablets, other oral products, and inhalation.

Beverages

Coffee

The world's primary source of caffeine is the coffee "bean" (the seed of the coffee plant), from which coffee is brewed. Caffeine content in coffee varies widely depending on the type of coffee bean and the method of preparation used;[177] even beans within a given bush can show variations in concentration. In general, one serving of coffee ranges from 80 to 100 milligrams, for a single shot (30 milliliters) of arabica-variety espresso, to approximately 100–125 milligrams for a cup (120 milliliters) of drip coffee.[178][179] Arabica coffee typically contains half the caffeine of the robusta variety.[177] In general, dark-roast coffee has very slightly less caffeine than lighter roasts because the roasting process reduces caffeine content of the bean by a small amount.[178][179]

Tea

Tea contains more caffeine than coffee by dry weight. A typical serving, however, contains much less, since tea is normally brewed more weakly than coffee. Also contributing to caffeine content are growing conditions, processing techniques, and other variables. Thus, teas contain varying amounts of caffeine.[180]

Tea contains small amounts of theobromine and slightly higher levels of theophylline than coffee. Preparation and many other factors have a significant impact on tea, and color is a very poor indicator of caffeine content. Teas like the pale Japanese green tea, gyokuro, for example, contain far more caffeine than much darker teas like lapsang souchong, which has very little.[180]

Soft drinks and energy drinks

Caffeine is also a common ingredient of soft drinks, such as cola, originally prepared from kola nuts. Soft drinks typically contain 0 to 55 milligrams of caffeine per 12 ounce serving.[181] By contrast, energy drinks, such as Red Bull, can start at 80 milligrams of caffeine per serving. The caffeine in these drinks either originates from the ingredients used or is an additive derived from the product of decaffeination or from chemical synthesis. Guarana, a prime ingredient of energy drinks, contains large amounts of caffeine with small amounts of theobromine and theophylline in a naturally occurring slow-release excipient.[182]

Other beverages

  • Mate is a drink popular in many parts of South America. Its preparation consists of filling a gourd with the leaves of the South American holly yerba mate, pouring hot but not boiling water over the leaves, and drinking with a straw, the bombilla, which acts as a filter so as to draw only the liquid and not the yerba leaves.[citation needed]
  • Guaraná seeds ("beans") are used in making the commercially sold beverage Guaraná Antarctica, which originated in Brazil and is currently the fifteenth most popular soft drink in the world.[citation needed]
  • The leaves of Ilex guayusa, the Ecuadorian holly tree, are placed in boiling water to make a guayusa tea, which is both brewed locally and sold commercially throughout the world.[citation needed]

Chocolate

Chocolate derived from cocoa beans contains a small amount of caffeine. The weak stimulant effect of chocolate may be due to a combination of theobromine and theophylline, as well as caffeine.[183] A typical 28-gram serving of a milk chocolate bar has about as much caffeine as a cup of decaffeinated coffee. By weight, dark chocolate has one to two times the amount of caffeine as coffee: 80–160 mg per 100 g.[171]

Tablets

No-Doz 100 mg caffeine tablets

Tablets offer the advantages over coffee and tea of convenience, known dosage, and avoiding concomitant sugar, acid and fluid intake. Manufacturers of caffeine tablets claim that using caffeine of pharmaceutical quality improves mental alertness.[citation needed] These tablets are commonly used by students studying for their exams and by people who work or drive for long hours.[184]

Other oral products

One U.S. company is marketing oral dissolvable caffeine strips.[185] Another intake route is SpazzStick, a caffeinated lip balm.[186] Alert Energy Caffeine Gum was introduced in the United States in 2013, but was voluntarily withdrawn after an announcement of an investigation by the FDA of the health effects of added caffeine in foods.[187]

Inhalants

Taking caffeine by inhalation was under scrutiny by some U.S. lawmakers in 2011.[188]

Combinations with other drugs

History

Discovery and spread of use

An old photo of a dozen old and middle-aged men sitting on the ground around a mat. A man in front sits next to a mortar and holds a bat, ready for grinding. A man opposite to him holds a long spoon.
Coffeehouse in Palestine, circa 1900

According to Chinese legend, the Chinese emperor Shennong, reputed to have reigned in about 3000 BCE, accidentally discovered tea when he noted that when certain leaves fell into boiling water, a fragrant and restorative drink resulted.[190] Shennong is also mentioned in Lu Yu's Cha Jing, a famous early work on the subject of tea.[191]

The earliest credible evidence of either coffee drinking or knowledge of the coffee tree appears in the middle of the fifteenth century, in the Sufi monasteries of the Yemenin southern Arabia.[192] From Mocha, coffee spread to Egypt and North Africa, and by the 16th century, it had reached the rest of the Middle East, Persia and Turkey. From the Middle East, coffee drinking spread to Italy, then to the rest of Europe, and coffee plants were transported by the Dutch to the East Indies and to the Americas.[193]

Kola nut use appears to have ancient origins. It is chewed in many West African cultures, individually or in a social setting, to restore vitality and ease hunger pangs.

The earliest evidence of cocoa bean use comes from residue found in an ancient Mayan pot dated to 600 BCE. Also, chocolate was consumed in a bitter and spicy drink called xocolatl, often seasoned with vanilla, chile pepper, and achiote. Xocolatl was believed to fight fatigue, a belief probably attributable to the theobromine and caffeine content. Chocolate was an important luxury good throughout pre-Columbian Mesoamerica, and cocoa beans were often used as currency.[citation needed]

Xocolatl was introduced to Europe by the Spaniards, and became a popular beverage by 1700. The Spaniards also introduced the cacao tree into the West Indies and the Philippines. It was used in alchemical processes, where it was known as "black bean".[citation needed]

The leaves and stems of the yaupon holly (Ilex vomitoria) were used by Native Americans to brew a tea called asi or the "black drink".[194] Archaeologists have found evidence of this use far into antiquity,[195] possibly dating to Late Archaic times.[194]

Chemical identification, isolation, and synthesis

Pierre Joseph Pelletier

In 1819, the German chemist Friedlieb Ferdinand Runge isolated relatively pure caffeine for the first time; he called it "Kaffebase" (i.e. a base that exists in coffee).[196] According to Runge, he did this at the behest of Johann Wolfgang von Goethe.[197][198] In 1821, caffeine was isolated both by the French chemist Pierre Jean Robiquet and by another pair of French chemists, Pierre-Joseph Pelletier and Joseph Bienaimé Caventou, according to Swedish chemist Jöns Jacob Berzelius in his yearly journal. Furthermore, Berzelius stated that the French chemists had made their discoveries independently of any knowledge of Runge's or each other's work.[199] However, Berzelius later acknowledged Runge's priority in the extraction of caffeine, stating:[200] "However, at this point, it should not remain unmentioned that Runge (in his Phytochemical Discoveries, 1820, pages 146–147) specified the same method and described caffeine under the name Caffeebase a year earlier than Robiquet, to whom the discovery of this substance is usually attributed, having made the first oral announcement about it at a meeting of the Pharmacy Society in Paris."

Pelletier's article on caffeine was the first to use the term in print (in the French form Caféine from the French word for coffee: café).[201] It corroborates Berzelius's account:

Caffeine, noun (feminine). Crystallizable substance discovered in coffee in 1821 by Mr. Robiquet. During the same period – while they were searching for quinine in coffee because coffee is considered by several doctors to be a medicine that reduces fevers and because coffee belongs to the same family as the cinchona [quinine] tree – on their part, Messrs. Pelletier and Caventou obtained caffeine; but because their research had a different goal and because their research had not been finished, they left priority on this subject to Mr. Robiquet. We do not know why Mr. Robiquet has not published the analysis of coffee which he read to the Pharmacy Society. Its publication would have allowed us to make caffeine better known and give us accurate ideas of coffee's composition ...

Robiquet was one of the first to isolate and describe the properties of pure caffeine,[202] whereas Pelletier was the first to perform an elemental analysis.[203]

In 1827, M. Oudry isolated "théine" from tea,[204] but it was later proved by Mulder[205] and by Carl Jobst[206] that theine was actually caffeine.

In 1895, German chemist Hermann Emil Fischer (1852–1919) first synthesized caffeine from its chemical components (i.e. a "total synthesis"), and two years later, he also derived the structural formula of the compound.[207] This was part of the work for which Fischer was awarded the Nobel Prize in 1902.[208]

Historic regulations

Because it was recognized that coffee contained some compound that acted as a stimulant, first coffee and later also caffeine has sometimes been subject to regulation. For example, in the 16th century Islamists in Mecca and in the Ottoman Empire made coffee illegal for some classes.[209][210][211] Charles II of England tried to ban it in 1676,[212][213] Frederick II of Prussia banned it in 1777,[214][215] and coffee was banned in Sweden at various times between 1756 and 1823.

In 1911, caffeine became the focus of one of the earliest documented health scares, when the US government seized 40 barrels and 20 kegs of Coca-Cola syrup in Chattanooga, Tennessee, alleging the caffeine in its drink was "injurious to health".[216] Although the judge ruled in favor of Coca-Cola, two bills were introduced to the U.S. House of Representatives in 1912 to amend the Pure Food and Drug Act, adding caffeine to the list of "habit-forming" and "deleterious" substances, which must be listed on a product's label.[217]

Society and culture

Regulations

The Food and Drug Administration (FDA) in the United States currently allows only beverages containing less than 0.02% caffeine;[218] but caffeine powder, which is sold as a dietary supplement, is unregulated.[219] It is a regulatory requirement that the label of most prepackaged foods must declare a list of ingredients, including food additives such as caffeine, in descending order of proportion. However, there is no regulatory provision for mandatory quantitative labeling of caffeine, (e.g., milligrams caffeine per stated serving size). There are a number of food ingredients that naturally contain caffeine. These ingredients must appear in food ingredient lists. However, as is the case for "food additive caffeine", there is no requirement to identify the quantitative amount of caffeine in composite foods containing ingredients that are natural sources of caffeine. While coffee or chocolate are broadly recognized as caffeine sources, some ingredients (e.g. guarana, yerba maté) are likely less recognized as caffeine sources. For these natural sources of caffeine, there is no regulatory provision requiring that a food label identify the presence of caffeine nor state the amount of caffeine present in the food.[220]

Consumption

Global consumption of caffeine has been estimated at 120,000 tonnes per year, making it the world's most popular psychoactive substance. This amounts to one serving of a caffeinated beverage for every person every day.[221]

Religions

Some Seventh-day Adventists, Church of God (Restoration) adherents, and Christian Scientists do not consume caffeine.[citation needed] Some from these religions believe that one is not supposed to consume a non-medical, psychoactive substance, or believe that one is not supposed to consume a substance that is addictive. The Church of Jesus Christ of Latter-day Saints has said the following with regard to caffeinated beverages: " . . . the Church revelation spelling out health practices (Doctrine and Covenants 89) does not mention the use of caffeine. The Church's health guidelines prohibit alcoholic drinks, smoking or chewing of tobacco, and 'hot drinks' – taught by Church leaders to refer specifically to tea and coffee."[222]

Gaudiya Vaishnavas generally also abstain from caffeine, because they believe it clouds the mind and over-stimulates the senses. To be initiated under a guru, one must have had no caffeine, alcohol, nicotine or other drugs, for at least a year.[citation needed]

Caffeinated beverages are widely consumed by Muslims today. In the 16th century, some Muslim authorities made unsuccessful attempts to ban them as forbidden "intoxicating beverages" under Islamic dietary laws.[223][224]

Other organisms

Caffeine effects on spider webs.
Caffeine effects on spider webs

Recently discovered bacteria Pseudomonas putida CBB5 can live on pure caffeine, and can cleave caffeine into carbon dioxide and ammonia.[225]

Caffeine is toxic to birds[226] and to dogs and cats,[227] and has a pronounced adverse effect on mollusks, various insects, and spiders.[228] This is at least partly due to a poor ability to metabolize the compound, causing higher levels for a given dose per unit weight.[229] Caffeine has also been found to enhance the reward memory of honeybees, improving the reproductive success of the pollen producing plants.[230]

Research

Caffeine has been used to double chromosomes in haploid wheat.[231]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 15: Reinforcement and Addictive Disorders". In Sydor A, Brown RY. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York: McGraw-Hill Medical. p. 375. ISBN 978-0-07-148127-4. Long-term caffeine use can lead to mild physical dependence. A withdrawal syndrome characterized by drowsiness, irritability, and headache typically lasts no longer than a day. True compulsive use of caffeine has not been documented.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  2. 2.0 2.1 2.2 Karch SB (2009). Karch's pathology of drug abuse (4th ed.). Boca Raton: CRC Press. pp. 229–230. ISBN 978-0-8493-7881-2. The suggestion has also been made that a caffeine dependence syndrome exists ... In one controlled study, dependence was diagnosed in 16 of 99 individuals who were evaluated. The median daily caffeine consumption of this group was only 357 mg per day (Strain et al., 1994).
    Since this observation was first published, caffeine addiction has been added as an official diagnosis in ICDM 9. This decision is disputed by many and is not supported by any convincing body of experimental evidence. ... All of these observations strongly suggest that caffeine does not act on the dopaminergic structures related to addiction, nor does it improve performance by alleviating any symptoms of withdrawal
    <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  3. 3.0 3.1 3.2 3.3 3.4 3.5 American Psychiatric Association (2013). "Substance-Related and Addictive Disorders" (PDF). American Psychiatric Publishing. pp. 1–2. Archived from the original (PDF) on 15 August 2015. Retrieved 10 July 2015. Substance use disorder in DSM-5 combines the DSM-IV categories of substance abuse and substance dependence into a single disorder measured on a continuum from mild to severe. ... Additionally, the diagnosis of dependence caused much confusion. Most people link dependence with “addiction” when in fact dependence can be a normal body response to a substance. ... DSM-5 will not include caffeine use disorder, although research shows that as little as two to three cups of coffee can trigger a withdrawal effect marked by tiredness or sleepiness. There is sufficient evidence to support this as a condition, however it is not yet clear to what extent it is a clinically significant disorder.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  4. 4.0 4.1 Introduction to Pharmacology (third ed.). Abingdon: CRC Press. 2007. pp. 222–223. ISBN 978-1-4200-4742-4.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  5. 5.0 5.1 5.2 5.3 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  6. 6.0 6.1 6.2 6.3 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  7. 7.00 7.01 7.02 7.03 7.04 7.05 7.06 7.07 7.08 7.09 7.10 7.11 7.12 7.13 7.14 "Caffeine". DrugBank. University of Alberta. 16 September 2013. Retrieved 8 August 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  8. 8.0 8.1 "Caffeine". Pubchem Compound. NCBI. Retrieved 16 October 2014.
    Boiling Point
    178 deg C (sublimes)
    Melting Point
    238 DEG C (ANHYD)
    <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  9. 9.0 9.1 "Caffeine". ChemSpider. Royal Society of Chemistry. Retrieved 16 October 2014. Experimental Melting Point:
    234–236 °C Alfa Aesar
    237 °C Oxford University Chemical Safety Data
    238 °C LKT Labs [C0221]
    237 °C Jean-Claude Bradley Open Melting Point Dataset 14937
    238 °C Jean-Claude Bradley Open Melting Point Dataset 17008, 17229, 22105, 27892, 27893, 27894, 27895
    235.25 °C Jean-Claude Bradley Open Melting Point Dataset 27892, 27893, 27894, 27895
    236 °C Jean-Claude Bradley Open Melting Point Dataset 27892, 27893, 27894, 27895
    235 °C Jean-Claude Bradley Open Melting Point Dataset 6603
    234–236 °C Alfa Aesar A10431, 39214
    Experimental Boiling Point:
    178 °C (Sublimes) Alfa Aesar
    178 °C (Sublimes) Alfa Aesar 39214
    <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  10. 10.0 10.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  11. Lovett R (24 September 2005). "Coffee: The demon drink?". New Scientist (2518). (Subscription required (help)).<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  12. WHO Model List of Essential Medicines (PDF) (18th ed.). World Health Organization. October 2013 [April 2013]. p. 34 [p. 38 of pdf]. Retrieved 23 December 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  13. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  14. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  15. 15.0 15.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  16. Mayo Clinic staff. "Pregnancy Nutrition: Foods to avoid during pregnancy". Mayo Clinic. Retrieved 15 April 2012.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  17. 17.0 17.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  18. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  19. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  20. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  21. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  22. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  23. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  24. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  25. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  26. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  27. 27.0 27.1 "Caffeine: Summary of Clinical Use". IUPHAR Guide to Pharmacology. The International Union of Basic and Clinical Pharmacology. Retrieved 13 February 2015.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  28. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  29. 29.0 29.1 29.2 Bolton S (1981). "Caffeine: Psychological Effects, Use and Abuse" (PDF). Orthomolecular Psychiatry. 10 (3): 202–211.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  30. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  31. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  32. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  33. 33.0 33.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  34. 34.0 34.1 34.2 34.3 34.4 34.5 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  35. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  36. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  37. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  38. 38.0 38.1 38.2 38.3 "It's Your Health – Caffeine". Health Canada. March 2010. Retrieved 8 November 2010.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  39. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  40. Levounis P, Herron AJ (2014). The Addiction Casebook. American Psychiatric Pub. p. 49. ISBN 978-1-58562-458-4.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  41. "Food Standards Agency publishes new caffeine advice for pregnant women". Retrieved 3 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  42. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  43. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  44. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  45. 45.0 45.1 45.2 45.3 45.4 45.5 Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE (March 1999). "Actions of caffeine in the brain with special reference to factors that contribute to its widespread use". Pharmacological Reviews. 51 (1): 83–133. PMID 10049999.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  46. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  47. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  48. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  49. Daniels JW, Molé PA, Shaffrath JD, Stebbins CL (July 1998). "Effects of caffeine on blood pressure, heart rate, and forearm blood flow during dynamic leg exercise". Journal of Applied Physiology. 85 (1): 154–9. PMID 9655769.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  50. Bracco D, Ferrarra JM, Arnaud MJ, Jéquier E, Schutz Y (October 1995). "Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women". The American Journal of Physiology. 269 (4 Pt 1): E671–8. PMID 7485480.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  51. 51.0 51.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  52. Boekema PJ, Samsom M, van Berge Henegouwen GP, Smout AJ (1999). "Coffee and gastrointestinal function: facts and fiction. A review". Scandinavian Journal of Gastroenterology. Supplement. 230 (230): 35–9. PMID 10499460.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  53. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  54. Sherwood L, Kell R (2009). Human Physiology: From Cells to Systems (1st Canadian ed.). Nelsen. pp. 613–9. ISBN 978-0-17-644107-4.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  55. Acheson KJ, Zahorska-Markiewicz B, Pittet P, Anantharaman K, Jéquier E (May 1980). "Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals". The American Journal of Clinical Nutrition. 33 (5): 989–97. PMID 7369170.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  56. Dulloo AG, Geissler CA, Horton T, Collins A, Miller DS (January 1989). "Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers". The American Journal of Clinical Nutrition. 49 (1): 44–50. PMID 2912010.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  57. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  58. "Caffeine in the diet". MedlinePlus, US National Library of Medicine. 30 April 2013. Retrieved 2 January 2015.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  59. Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL (November 2001). "Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes". The American Journal of Clinical Nutrition. 74 (5): 694–700. PMID 11684540.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  60. 60.0 60.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  61. Modulation of adenosine receptor expression in the proximal tubule: a novel adaptive mechanism to regulate renal salt and water metabolism Am. J. Physiol. Renal Physiol. 1 July 2008 295:F35-F36
  62. Anahad O'connor (4 March 2008). "Really? The claim: caffeine causes dehydration". New York Times. Retrieved 3 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  63. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  64. 64.0 64.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  65. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  66. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  67. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  68. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  69. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  70. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  71. Kohn R, Keller M (2015). "Chapter 34 Emotions". In Tasman A, Kay J, Lieberman JA, First MB, Riba M. Psychiatry, 2 Volume Set. Volume 1. New York: John Wiley & Sons. pp. 557–558. ISBN 978-1-118-84547-9. Table 34-12... Caffeine Intoxication – Euphoria<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  72. Hrnčiarove J, Barteček R (2017). "8. Substance Dependence". In Hosák L, Hrdlička M, et al. Psychiatry and Pedopsychiatry. Prague: Karolinum Press. pp. 153–154. ISBN 9788024633787. At a high dose, caffeine shows a euphoric effect.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  73. Schulteis G (2010). "Brain stimulation and addiction". In Koob GF, Le Moal M, Thompson RF. Encyclopedia of Behavioral Neuroscience. Elsevier. p. 214. ISBN 978-0-08-091455-8. Therefore, caffeine and other adenosine antagonists, while weakly euphoria-like on their own, may potentiate the positive hedonic efficacy of acute drug intoxication and reduce the negative hedonic consequences of drug withdrawal.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  74. Salerno BB, Knights EK (2010). Pharmacology for health professionals (3rd ed.). Chatswood, N.S.W.: Elsevier Australia. p. 433. ISBN 978-0-7295-3929-6. In contrast to the amphetamines, caffeine does not cause euphoria, stereotyped behaviors or psychoses.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  75. Ebenezer I (2015). Neuropsychopharmacology and Therapeutics. John Wiley & Sons. p. 18. ISBN 978-1-118-38578-4. However, in contrast to other psychoactive stimulants, such as amphetamine and cocaine, caffeine and the other methylxanthines do not produce euphoria, stereotyped behaviors or psychotic like symptoms in large doses.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  76. Rang HP, Ritter JM, Flower RJ, Henderson G (2014). Rang & Dale's Pharmacology E-Book (8th ed.). Elsevier Health Sciences. pp. 453, 594. ISBN 978-0-7020-5497-6. By comparison with amphetamines, methylxanthines produce less locomotor stimulation and do not induce euphoria, stereotyped behaviour patterns or a psychotic state, but their effects on fatigue and mental function are similar. 
    Table 37.2 ... Psychomotor stimulants ... Drugs that cause wakefulness and euphoria ... Amphetamines, cocaine, methylphenidate, caffeine
    <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  77. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  78. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  79. Riba A, Tasman J, Kay JA, Lieberman MB, First MB (2014). Psychiatry (Fourth ed.). p. 1446. ISBN 978-1-118-75336-1.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  80. Fishchman N, Mello N. Testing for Abuse Liability of Drugs in Humans (PDF). 5600 Fishers Lane Rockville, MD 20857: U.S. Department of Health and Human Services Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse. p. 179.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  81. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  82. Miller PM (2013). "Chapter III: Types of Addiction". Principles of addiction comprehensive addictive behaviors and disorders (1st ed.). Elsevier Academic Press. p. 784. ISBN 978-0-12-398361-9. Retrieved 11 July 2015. Astrid Nehlig and colleagues present evidence that in animals caffeine does not trigger metabolic increases or dopamine release in brain areas involved in reinforcement and reward. A single photon emission computed tomography (SPECT) assessment of brain activation in humans showed that caffeine activates regions involved in the control of vigilance, anxiety, and cardiovascular regulation but did not affect areas involved in reinforcement and reward.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  83. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  84. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  85. 85.0 85.1 "ICD-10 Version:2015". World Health Organization. 2015. Retrieved 10 July 2015.
    F15 Mental and behavioural disorders due to use of other stimulants, including caffeine ...

    .2 Dependence syndrome
    A cluster of behavioural, cognitive, and physiological phenomena that develop after repeated substance use and that typically include a strong desire to take the drug, difficulties in controlling its use, persisting in its use despite harmful consequences, a higher priority given to drug use than to other activities and obligations, increased tolerance, and sometimes a physical withdrawal state.
    The dependence syndrome may be present for a specific psychoactive substance (e.g. tobacco, alcohol, or diazepam), for a class of substances (e.g. opioid drugs), or for a wider range of pharmacologically different psychoactive substances. [Includes:]
    Chronic alcoholism
    Dipsomania
    Drug addiction
    <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  86. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  87. Association American Psychiatry (2013). Diagnostic and statistical manual of mental disorders : DSM-5 (5th ed.). Washington [etc.]: American Psychiatric Publishing. pp. 792–795. ISBN 978-0-89042-555-8.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  88. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  89. 89.0 89.1 89.2 "Information about caffeine dependence". Caffeinedependence.org. Johns Hopkins Medicine. 9 July 2003. Archived from the original on 23 May 2012. Retrieved 25 May 2012.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  90. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  91. 91.0 91.1 91.2 91.3 91.4 91.5 91.6 91.7 91.8 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).[page needed]
  92. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  93. 93.0 93.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  94. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  95. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  96. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  97. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  98. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  99. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  100. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  101. Gilmore B, Michael M (February 2011). "Treatment of acute migraine headache". American Family Physician. 83 (3): 271–80. PMID 21302868.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  102. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  103. 103.0 103.1 103.2 "Caffeine (Systemic)". MedlinePlus. 25 May 2000. Archived from the original on 23 February 2007. Retrieved 3 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  104. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  105. Iancu I, Olmer A, Strous RD (2007). "Caffeinism: History, clinical features, diagnosis, and treatment". In Smith BD, Gupta U, Gupta BS. Caffeine and Activation Theory: Effects on Health and Behavior. CRC Press. pp. 331–344. ISBN 978-0-8493-7102-8. Retrieved 15 January 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  106. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). American Psychiatric Association. ISBN 978-0-89042-062-1.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  107. "Caffeine overdose". MedlinePlus. 4 April 2006. Retrieved 3 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  108. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  109. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  110. "FDA Consumer Advice on Powdered Pure Caffeine". FDA. Retrieved 20 August 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  111. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  112. Murray Carpenter. "Caffeine powder poses deadly risks". New York Times. Retrieved 18 May 2015.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  113. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  114. Cheston P, Smith L (11 October 2013). "Man died after overdosing on caffeine mints". The Independent. Retrieved 13 October 2013.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  115. Prynne M (11 October 2013). "Warning over caffeine sweets after father dies from overdose". The Telegraph. Retrieved 13 October 2013.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  116. Fricker M (12 October 2013). "John Jackson: Family of dad who died from caffeine overdose after eating MINTS want them removed from sale". Daily Mirror. Retrieved 13 October 2013.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  117. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  118. 118.0 118.1 118.2 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  119. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  120. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  121. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  122. "World of Caffeine". World of Caffeine. 15 June 2013. Retrieved 19 December 2013.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  123. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  124. "Caffeine". IUPHAR. International Union of Basic and Clinical Pharmacology. Retrieved 2 November 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  125. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  126. 126.0 126.1 126.2 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  127. 127.0 127.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  128. 128.0 128.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  129. 129.0 129.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  130. 130.0 130.1 130.2 130.3 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  131. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  132. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  133. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  134. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  135. 135.0 135.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  136. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  137. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  138. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  139. Brødbaek HB, Damkier P (May 2007). "[The treatment of hyperemesis gravidarum with chlorobutanol-caffeine rectal suppositories in Denmark: practice and evidence]". Ugeskrift for Laeger (in Danish). 169 (22): 2122–3. PMID 17553397. <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  140. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  141. "Drug Interaction: Caffeine Oral and Fluvoxamine Oral". Medscape Multi-Drug Interaction Checker.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  142. "Caffeine". The Pharmacogenetics and Pharmacogenomics Knowledge Base. Retrieved 25 October 2010.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  143. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  144. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value). open access publication - free to read
  145. 145.0 145.1 Susan Budavari, ed. (1996). The Merck Index (12th ed.). Whitehouse Station, NJ: Merck & Co., Inc. p. 1674.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  146. This is the pKa for protonated caffeine, given as a range of values included in Brittain HG, Prankerd RJ (2007). Profiles of Drug Substances, Excipients and Related Methodology, volume 33: Critical Compilation of pKa Values for Pharmaceutical Substances. Academic Press. p. 15. ISBN 978-0-12-260833-9. Retrieved 15 January 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  147. Klosterman L (2006). The Facts About Caffeine (Drugs). Benchmark Books (NY). p. 43. ISBN 0-7614-2242-0.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  148. Vallombroso T (2001). Organic Chemistry Pearls of Wisdom. Boston Medical Publishing Corp. p. 43. ISBN 978-1-58409-016-8.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  149. Keskineva N. "Chemistry of Caffeine" (PDF). Chemistry Department, East Stroudsburg University. Retrieved 2 January 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  150. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  151. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  152. Williams R (September 21, 2016). "How Plants Evolved Different Ways to Make Caffeine".<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  153. "Caffeine biosynthesis". The Enzyme Database. Trinity College Dublin. Retrieved 24 September 2011.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  154. 154.0 154.1 Temple NJ, Wilson T (2003). Beverages in Nutrition and Health. Totowa, NJ: Humana Press. p. 172. ISBN 978-1-58829-173-8.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  155. 155.0 155.1 US patent 2785162, Swidinsky J, Baizer MM, "Process for the formylation of a 5-nitrouracil", published 12 March 1957, assigned to New York Quinine and Chemical Works, Inc. 
  156. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  157. Simon Tilling. "Crystalline Caffeine". Bristol University. Retrieved 3 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  158. 158.0 158.1 158.2 Senese F (20 September 2005). "How is coffee decaffeinated?". General Chemistry Online. Retrieved 3 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  159. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  160. Baselt R (2011). Disposition of Toxic Drugs and Chemicals in Man (9th ed.). Seal Beach, CA: Biomedical Publications. pp. 236–9. ISBN 978-0-931890-08-6.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  161. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  162. Kennerly J (22 September 1995). "N Substituted Xanthines: A Caffeine Analog Information File". Retrieved 6 November 2015.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  163. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  164. "Which Plants Contain Caffeine?". medscape.com.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  165. For more information, see Alejandro Lopez-Ortiz. "Frequently Asked Questions about Coffee and Caffeine".<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  166. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  167. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  168. Baumann TW (1984). "Metabolism and excretion of caffeine during germination of Coffea arabica L". Plant and Cell Physiology. 25 (8): 1431–6.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  169. Balentine DA, Harbowy ME, Graham HN (1998). G Spiller, ed. Tea: the Plant and its Manufacture; Chemistry and Consumption of the Beverage. Caffeine.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>[clarification needed]
  170. "Caffeine Content of Food and Drugs". Nutrition Action Health Newsletter. Center for Science in the Public Interest. 1996. Archived from the original on 14 June 2007. Retrieved 3 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  171. 171.0 171.1 "Caffeine Content of Beverages, Foods, & Medications". The Vaults of Erowid. 7 July 2006. Retrieved 3 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  172. "Caffeine Content of Drinks". Caffeine Informer. Retrieved 8 December 2013.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  173. 173.0 173.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  174. 174.0 174.1 Richardson B (2009). "Too Easy to be True. De-bunking the At-Home Decaffeination Myth". Elmwood Inn. Retrieved 12 January 2012.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  175. "Traditional Yerba Mate in Biodegradable Bag". Guayaki Yerba Mate. Retrieved 17 July 2010.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  176. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  177. 177.0 177.1 "Caffeine". International Coffee Organization. Retrieved 1 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  178. 178.0 178.1 "Coffee and Caffeine FAQ: Does dark roast coffee have less caffeine than light roast?". Retrieved 2 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  179. 179.0 179.1 "All About Coffee: Caffeine Level". Jeremiah's Pick Coffee Co. Archived from the original on 18 March 2008. Retrieved 3 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  180. 180.0 180.1 Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  181. "Nutrition and healthy eating". Mayo Clinic. Retrieved 18 November 2015.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  182. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  183. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  184. Weinberg BA, Bealer BK (2001). The World of caffeine: The Science and Culture of the World's Most Popular Drug. Routledge. p. 195. ISBN 978-0-415-92723-9. Retrieved 15 January 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  185. "LeBron James Shills for Sheets Caffeine Strips, a Bad Idea for Teens, Experts Say". Abcnews.go.com. ABC News. 10 June 2011. Retrieved 25 May 2012.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  186. Nancy Shute (15 April 2007). "Over The Limit:Americans young and old crave high-octane fuel, and doctors are jittery". US News and World Reports. Archived from the original on 8 January 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  187. "F.D.A. Inquiry Leads Wrigley to Halt 'Energy Gum' Sales". New York Times. Associated Press. 8 May 2013. Retrieved 9 May 2013.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  188. http://www.washingtonpost.com/business/controversy-over-inhaled-caffeine-grows-as-as-sen-schumer-calls-for-fda-probe/2011/12/22/gIQAjQaVDP_story.html[dead link]
  189. "Food Additives & Ingredients > Caffeinated Alcoholic Beverages". fda.gov. Food and Drug Administration. 17 November 2010. Retrieved 24 January 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  190. Evans JC (1992). Tea in China: The History of China's National Drink. Greenwood Press. p. 2. ISBN 978-0-313-28049-8.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  191. Yu L (1995). The Classic of Tea: Origins & Rituals. Ecco Pr. ISBN 978-0-88001-416-8.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>[page needed]
  192. Weinberg BA, Bealer BK (2001). The World of Caffeine: The Science and Culture of the World's Most Popular Drug. Routledge. pp. 3–4. ISBN 978-0-415-92723-9.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  193. Meyers H (7 March 2005). ""Suave Molecules of Mocha" – Coffee, Chemistry, and Civilization". New Partisan. Archived from the original on 9 March 2005. Retrieved 3 February 2007.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  194. 194.0 194.1 Fairbanks CH (2004). "The function of black drink among the Creeks". In Hudson MC. Black Drink. University of Georgia Press. p. 123. ISBN 978-0-8203-2696-2.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  195. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  196. Runge FF (1820). Neueste phytochemische Entdeckungen zur Begründung einer wissenschaftlichen Phytochemie. Berlin: G. Reimer. pp. 144–159. Retrieved 8 January 2014. Unknown parameter |trans_title= ignored (help)<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  197. In 1819, Runge was invited to show Goethe how belladonna caused dilation of the pupil, which Runge did, using a cat as an experimental subject. Goethe was so impressed with the demonstration that: "Nachdem Goethe mir seine größte Zufriedenheit sowol über die Erzählung des durch scheinbaren schwarzen Staar Geretteten, wie auch über das andere ausgesprochen, übergab er mir noch eine Schachtel mit Kaffeebohnen, die ein Grieche ihm als etwas Vorzügliches gesandt. "Auch diese können Sie zu Ihren Untersuchungen brauchen," sagte Goethe. Er hatte recht; denn bald darauf entdeckte ich darin das, wegen seines großen Stickstoffgehaltes so berühmt gewordene Coffein." (After Goethe had expressed to me his greatest satisfaction regarding the account of the man [whom I'd] rescued [from serving in Napoleon's army] by apparent "black star" [i.e., amaurosis, blindness] as well as the other, he handed me a carton of coffee beans, which a Greek had sent him as a delicacy. "You can also use these in your investigations," said Goethe. He was right; for soon thereafter I discovered therein caffeine, which became so famous on account of its high nitrogen content.)
    This account appeared in Runge's book Hauswirtschaftlichen Briefen (Domestic Letters [i.e., personal correspondence]) of 1866. It was reprinted in: Johann Wolfgang von Goethe with F.W. von Biedermann, ed., Goethes Gespräche, vol. 10: Nachträge, 1755–1832 (Leipzig, (Germany): F.W. v. Biedermann, 1896), pages 89–96; see especially page 95.
  198. Weinberg BA, Bealer BK (2001). The World of Caffeine: The Science and Culture of the World's Most Popular Drug. Routledge. pp. xvii–xxi. ISBN 978-0-415-92723-9.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  199. Berzelius, Jöns Jakob (1825). "Jahres-Bericht über die Fortschritte der physischen Wissenschaften von Jacob Berzelius" (in German). 4: 180. Unknown parameter |trans_title= ignored (help) <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles> From page 180: "Caféin ist eine Materie im Kaffee, die zu gleicher Zeit, 1821, von Robiquet und Pelletier und Caventou entdekt wurde, von denen aber keine etwas darüber im Drucke bekannt machte." (Caffeine is a material in coffee, which was discovered at the same time, 1821, by Robiquet and [by] Pelletier and Caventou, by whom however nothing was made known about it in the press.)
  200. Berzelius JJ (1828). Jahres-Bericht über die Fortschritte der physischen Wissenschaften von Jacob Berzelius (in German). 7. p. 270. Unknown parameter |trans_title= ignored (help) <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles> From page 270: "Es darf indessen hierbei nicht unerwähnt bleiben, dass Runge (in seinen phytochemischen Entdeckungen 1820, p. 146-7.) dieselbe Methode angegeben, und das Caffein unter dem Namen Caffeebase ein Jahr eher beschrieben hat, als Robiquet, dem die Entdeckung dieser Substanz gewöhnlich zugeschrieben wird, in einer Zusammenkunft der Societé de Pharmacie in Paris die erste mündliche Mittheilung darüber gab." (However, at this point, it should not remain unmentioned that Runge (in his Phytochemical Discoveries, 1820, pages 146–147) specified the same method and described caffeine under the name Caffeebase a year earlier than Robiquet, to whom the discovery of this substance is usually attributed, having made the first oral announcement about it at a meeting of the Pharmacy Society in Paris.)
  201. Pelletier, Pierre Joseph (1822). "Cafeine". Dictionnaire de Médecine (in French). 4. Paris: Béchet Jeune. pp. 35–36. Retrieved 3 March 2011. <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  202. Robiquet, Pierre Jean (1823). "Café". Dictionnaire Technologique, ou Nouveau Dictionnaire Universel des Arts et Métiers (in French). 4. Paris: Thomine et Fortic. pp. 50–61. Retrieved 3 March 2011. <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  203. Dumas; Pelletier (1823). "Recherches sur la composition élémentaire et sur quelques propriétés caractéristiques des bases salifiables organiques". Annales de Chimie et de Physique (in French). 24: 163–191. Unknown parameter |trans_title= ignored (help) <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  204. Oudry M (1827). "Note sur la Théine". Nouvelle bibliothèque médicale (in French). 1: 477–479. <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  205. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  206. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  207. Fischer began his studies of caffeine in 1881; however, understanding of the molecule's structure long eluded him. In 1895 he synthesized caffeine, but only in 1897 did he finally fully determine its molecular structure.
    • Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
    • Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
    • Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
    • Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
    • Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  208. Hj. Théel (1902). "Nobel Prize Presentation Speech". Retrieved 3 August 2009.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  209. Brown DW (2004). A new introduction to Islam. Chichester, West Sussex: Wiley-Blackwell. pp. 149–51. ISBN 978-1-4051-5807-7.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  210. Ágoston, Gábor; Masters, Bruce (2009). Encyclopedia of the Ottoman Empire. p. 138. ISBN 978-1-4381-1025-7.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  211. Hopkins K (24 March 2006). "Food Stories: The Sultan's Coffee Prohibition". Accidental Hedonist. Retrieved 3 January 2010.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  212. "By the King. A PROCLAMATION FOR THE Suppression of Coffee-Houses". Retrieved 18 March 2012.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  213. Pendergrast 2001, p. 13
  214. Pendergrast 2001, p. 11
  215. Bersten 1999, p. 53
  216. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  217. "The Rise and Fall of Cocaine Cola". Lewrockwell.com. Retrieved 25 May 2012.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  218. "CFR – Code of Federal Regulations Title 21". U.S. Food and Drug Administration. 21 August 2015. Retrieved 23 November 2015.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  219. Sanner A (19 July 2014). "Sudden death of Ohio teen highlights dangers of caffeine powder". The Globe and Mail. Columbus, Ohio: Phillip Crawley. The Associated Press. Retrieved 23 November 2015.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  220. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  221. Geoffrey Burchfield (1997). Meredith Hopes, ed. "What's your poison: caffeine". Australian Broadcasting Corporation. Retrieved 15 January 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  222. "Mormonism in the News: Getting It Right August 29". The Church of Jesus Christ of Latter-Day Saints. 2012. Retrieved 17 April 2016.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  223. Juan Eduardo Campo (1 January 2009). Encyclopedia of Islam. Infobase Publishing. p. 154. ISBN 978-1-4381-2696-8. Retrieved 1 November 2012.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  224. Daniel W. Brown (24 August 2011). A New Introduction to Islam. John Wiley & Sons. p. 149. ISBN 978-1-4443-5772-1.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  225. "Newly Discovered Bacteria Lives on Caffeine". Blogs.scientificamerican.com. 24 May 2011. Retrieved 19 December 2013.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  226. Paul L. "Why Caffeine is Toxic to Birds". HotSpot for Birds. Advin Systems. Retrieved 29 February 2012.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  227. "Caffeine". Retrieved 12 September 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  228. Noever R, Cronise J, Relwani RA (29 April 1995). "Using spider-web patterns to determine toxicity". NASA Tech Briefs. New Scientist magazine. 19 (4): 82.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  229. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  230. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  231. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).

Bibliography

  • Bersten I (1999). Coffee, Sex & Health: A history of anti-coffee crusaders and sexual hysteria. Sydney: Helian Books. ISBN 978-0-9577581-0-0.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Pendergrast M (2001) [1999]. Uncommon Grounds: The History of Coffee and How It Transformed Our World. London: Texere. ISBN 1-58799-088-1.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>

External links

Template:Cytochrome P450 modulators